The Medicines Company

Hetero Labs Limited

Targanta Therapeutics, Inc.

Ranga Reddy

Adel Rafai Far

Evelyne Dietrich

Ting Kang

Kelly Tanaka

Theodore John Nitz

Carl Thomas Wild

Parthasaradhi Reddy Bandi

Rathnakar Reddy Kura

Panduranga Reddy Adulla

David Eugene Martin

David Krupadanam Gazula Levi

Stephane Ciblat

Eswara Rao Bammidi

Yanick LaFontaine

Yannick Stephane Rose

Yanick Lafontaine

The present invention relates to novel betulinic proline imidazole derivatives and related compounds, compositions useful for therapeutic treatment of viral diseases and particularly HIV mediated diseases. 

Betulinic proline imidazole derivatives as HIV inhibitors

The invention relates to derivatives of glycopeptide and lipoglycopeptide antibiotics possessing an altered ionization state with respect to the parent glycopeptide or lipoglycopeptide antibiotic, and having the ability to be regenerated as the parent glycopeptide or lipoglycopeptide antibiotic under physiological conditions. These compounds are useful as antibiotics for the prevention and/or the treatment of bacterial infections.

Glycopeptide and lipoglycopeptide antibiotics with improved solubility

The present invention relates to phosphonated Rifamycins, and methods of making and using such compounds. These compounds are useful as antibiotics for prophylaxis and/or the treatment of bone and joint infections, especially for the prophylaxis and/or treatment of osteomyelitis.

Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections

Phosphonated Rifamycins and uses thereof for the prevention and treatment of bone and joint infections

Growing community of inventors

Hyderabad Telangana, India

Ranga Reddy